Article Details
Retrieved on: 2024-05-14 13:58:18
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the concerns and long-term data surrounding the use of CD20-targeting medications in autoimmune diseases, emphasizing minimal risks but the need for vigilant monitoring and patient communication, particularly in pregnancy contexts related to multiple sclerosis.
Article found on: www.neurologylive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here